Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regadenoson Stress CMR in Suspected CAD
NCT00871260Phase 4Completed
- Sponsor
- University of Chicago
- Start
- Apr 2009
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of regadenoson in coronary artery disease (CAD), sponsored by University of Chicago. Started Apr 2009; status: completed.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00871260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00871260.